Cerulean Pharma (CERU) Tops Q3 EPS by 5c

Cerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.36), $0.05 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M